XML 145 R137.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Payments - Summary of Performance Rights Granted (Detail) - Share consolidation adjustment [member]
 12 Months Ended
Jun. 30, 2025
shares
$ / shares
Jun. 30, 2024
shares
$ / shares
Jun. 30, 2023
shares
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Balance at start of the fiscal year Number 2,161,392 [1] 1,893,081 [1] 1,339,621
Granted during the fiscal year Number 0 768,311 1,624,499
Exercised during the fiscal year Number (950,280) (500,000) (706,173)
Lapsed during the fiscal year Number 0 0 (364,866)
Balance at end of the end fiscal year Number 1,211,112 2,161,392 [1] 1,893,081 [1]
Vested and exercisable at end of the fiscal year Number 0 231,517 0
November 1, 2019 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date   November 1, 2019 November 1, 2019
Type of performance right granted   Director rights Director rights
Fair value | $ / shares   $ 0.28 [1] $ 0.28 [2]
Balance at start of the fiscal year Number 0 500,000 [1] 1,000,000
Granted during the fiscal year Number   0 0
Exercised during the fiscal year Number   (500,000) (500,000)
Lapsed during the fiscal year Number   0 0
Balance at end of the end fiscal year Number   0 500,000 [1]
Vested and exercisable at end of the fiscal year Number   0 0
November 23, 2022 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date November 23, 2022 November 23, 2022 November 23, 2022
Type of performance right granted Director rights Director rights Director rights
Fair value | $ / shares $ 0.31 [3] $ 0.31 [1] $ 0.31 [2]
Balance at start of the fiscal year Number 1,166,667 [1] 1,166,667 [1] 0
Granted during the fiscal year Number 0 0 1,166,667
Exercised during the fiscal year Number (388,889) 0 0
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 777,778 1,166,667 [1] 1,166,667 [1]
Vested and exercisable at end of the fiscal year Number 0 0 0
December 1, 2021 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date December 1, 2021 December 1, 2021 December 1, 2021
Type of performance right granted Director rights Director rights Director rights
Fair value | $ / shares $ 0.49 [3] $ 0.49 [1] $ 0.49 [2]
Balance at start of the fiscal year Number 226,414 [1] 226,414 [1] 339,621
Granted during the fiscal year Number 0 0 0
Exercised during the fiscal year Number (226,414) 0 (113,207)
Lapsed during the fiscal year Number 0 0 0
Balance at end of the end fiscal year Number 0 226,414 [1] 226,414 [1]
Vested and exercisable at end of the fiscal year Number 0 113,207 0
November 23, 2022 [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date     November 23, 2022
Type of performance right granted     Director rights
Fair value | $ / shares [2]     $ 0.31
Balance at start of the fiscal year Number   0 0
Granted during the fiscal year Number     457,832
Exercised during the fiscal year Number     (92,966)
Lapsed during the fiscal year Number [2]     (364,866)
Balance at end of the end fiscal year Number     0
Vested and exercisable at end of the fiscal year Number     0
October 24, 2023 [Member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date October 24, 2023 October 24, 2023  
Type of performance right granted Director rights Director rights  
Fair value | $ / shares $ 0.32 [3] $ 0.32 [1]  
Balance at start of the fiscal year Number [1] 178,356 0  
Granted during the fiscal year Number 0 178,356  
Exercised during the fiscal year Number (78,356) 0  
Lapsed during the fiscal year Number 0 0  
Balance at end of the end fiscal year Number 100,000 178,356 [1] 0 [1]
Vested and exercisable at end of the fiscal year Number 0 28,356  
October 24, 2023 [Member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Grant date October 24, 2023 October 24, 2023  
Type of performance right granted Director rights Director rights  
Fair value | $ / shares $ 0.32 [3] $ 0.32 [1]  
Balance at start of the fiscal year Number [1] 589,955 0  
Granted during the fiscal year Number 0 589,955  
Exercised during the fiscal year Number (256,621) 0  
Lapsed during the fiscal year Number 0 0  
Balance at end of the end fiscal year Number 333,334 589,955 [1] 0 [1]
Vested and exercisable at end of the fiscal year Number 0 89,954  
[1] The weighted average share price on the exercising date during the financial year 2024 is $0.285.
[2] The change during the year represents derecognition due to the cessation of the director.
[3] The weighted average share price on the exercising date during the financial year 2025 is $0.332.